FMR LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$92,000
-99.5%
986
-99.7%
0.00%
-100.0%
Q3 2021$17,855,000
-7.4%
299,832
+6.1%
0.00%
-50.0%
Q2 2021$19,280,000
-24.6%
282,696
-23.3%
0.00%0.0%
Q1 2021$25,560,000
-24.3%
368,357
-16.2%
0.00%
-33.3%
Q4 2020$33,753,000
-46.7%
439,331
-48.1%
0.00%
-50.0%
Q3 2020$63,303,000
-14.6%
846,426
-28.1%
0.01%
-25.0%
Q2 2020$74,088,000
+47.7%
1,176,935
-1.5%
0.01%
+14.3%
Q1 2020$50,158,000
-8.4%
1,194,253
-1.0%
0.01%
+16.7%
Q4 2019$54,767,000
-2.1%
1,205,790
-1.4%
0.01%
-14.3%
Q3 2019$55,949,000
-53.5%
1,222,387
-40.4%
0.01%
-50.0%
Q2 2019$120,196,000
+29.4%
2,050,062
-1.1%
0.01%
+27.3%
Q1 2019$92,889,000
+14.2%
2,072,048
-0.8%
0.01%0.0%
Q4 2018$81,342,000
-40.1%
2,088,367
-29.3%
0.01%
-26.7%
Q3 2018$135,900,000
-31.7%
2,953,079
-35.2%
0.02%
-34.8%
Q2 2018$198,846,000
-6.0%
4,560,674
-14.9%
0.02%
-8.0%
Q1 2018$211,592,000
+93.8%
5,356,758
+66.6%
0.02%
+92.3%
Q4 2017$109,201,000
+33.2%
3,214,616
+0.0%
0.01%
+30.0%
Q3 2017$81,956,000
+4752.3%
3,213,963
+3110.7%
0.01%
Q2 2017$1,689,000100,1010.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 4,190,000$321,918,0005.54%
Prosight Management, LP 145,700$11,194,0005.17%
Integral Health Asset Management, LLC 200,000$15,366,0004.57%
Copernicus Capital Management, LLC 3,740$287,0004.47%
GREAT POINT PARTNERS LLC 345,120$26,516,0004.31%
Asymmetry Capital Management, L.P. 101,245$7,779,0003.55%
First Light Asset Management, LLC 321,967$24,737,0001.83%
DAFNA Capital Management LLC 76,815$5,902,0001.76%
SECTORAL ASSET MANAGEMENT INC 320,059$24,590,0001.73%
Nicholas Investment Partners, LP 276,633$21,254,0001.64%
View complete list of ARENA PHARMACEUTICALS INC shareholders